1-May-2026
Market Chameleon (Tue, 28-Apr 4:49 AM ET)
Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors
Business Wire (Tue, 28-Apr 8:35 AM ET)
HIMS Bull Put Spread is Attractively Offered at $1.09; Theoretical Value $0.98
Market Chameleon (Tue, 21-Apr 10:18 AM ET)
HIMS Iron Condor Can Make 53% in Next 8 Days
Market Chameleon (Tue, 21-Apr 9:59 AM ET)
Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026
Business Wire (Mon, 13-Apr 4:05 PM ET)
Business Wire (Fri, 3-Apr 5:50 PM ET)
Globe Newswire (Wed, 1-Apr 2:07 PM ET)
Novo Nordisk's FDA-Approved GLP-1s Now Available With Hims & Hers
Business Wire (Thu, 26-Mar 12:00 PM ET)
Hims & Hers Names Kathryn Beiser as Chief Communications Officer
Business Wire (Tue, 10-Mar 8:08 PM ET)
Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers
Business Wire (Tue, 10-Mar 9:00 AM ET)
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Hims & Hers Health Class A trades on the NYSE stock market under the symbol HIMS.
As of May 1, 2026, HIMS stock price climbed to $27.41 with 13,645,719 million shares trading.
HIMS has a beta of 2.53, meaning it tends to be more sensitive to market movements. HIMS has a correlation of 0.12 to the broad based SPY ETF.
HIMS has a market cap of $6.33 billion. This is considered a Mid Cap stock.
Last quarter Hims & Hers Health Class A reported $618 million in Revenue and $.08 earnings per share. This fell short of revenue expectation by $-207,922 and exceeded earnings estimates by $.05.
In the last 3 years, HIMS traded as high as $72.98 and as low as $5.65.
The top ETF exchange traded funds that HIMS belongs to (by Net Assets): IJH, VTI, IWM, VB, VBK.
HIMS has underperformed the market in the last year with a price return of -24.2% while the SPY ETF gained +30.4%. HIMS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +1.2% and -4.9%, respectively, while the SPY returned +4.4% and +1.5%, respectively.
HIMS support price is $25.42 and resistance is $28.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HIMS shares will trade within this expected range on the day.
